Filament’s Sanofi SNY Stock Holding History

Filament’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,300	Closed	-$213K	–	56
2016 Q1	$213K	Sell	5,300 -500	-9%	-$20.1K	0.1%	58
2015 Q4	$247K	Buy	+5,800	New	+$267K	0.12%	54

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Filament's SNY Position: Q2 2016 in Review

Filament sold out of Sanofi (SNY) in Q2 2016, closing a stake of 5,300 shares — an estimated $213K sold.

Filament first reported a position in SNY in Q4 2015 and held it in 2 quarters. The position peaked at $247K in Q4 2015. 450 funds tracked by Wall St. Rank hold SNY as of Q2 2016.

Filament reported no remaining Sanofi position as of Q2 2016 after selling out during the quarter.
Filament sold 5,300 Sanofi shares in Q2 2016, an estimated $213K.
Filament first reported a position in Sanofi in Q4 2015 and held it in 2 quarters.
Filament's Sanofi position peaked at $247K in Q4 2015.
450 funds tracked by Wall St. Rank held Sanofi as of Q2 2016.

Based on Filament's 13F filing for Q2 2016, filed 28 Jul 2016.